Navigation Links
HealthMedia and Aetna to Study Online Insomnia and Depression Interventions
Date:6/19/2008

d depression.

About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 36.7 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. http://www.aetna.com

About HealthMedia, Inc.

HealthMedia, Inc. is the global leader in scalable behavior change interventions with outcomes. HealthMedia's proven outcomes increase compliance, reduce medical utilization, and increase productivity -- boosting profitability for health plans, employers, pharmaceutical companies, and behavioral health organizations. A fusion of their own unique technology and proven behavioral science, HealthMedia delivers individually tailored behavior change interventions for health and wellness, disease management, behavioral health, and medication compliance. Clients include Kaiser Permanente, UPS, Cleveland Clinic, Johnson & Johnson, GSK, and eight Blue Cross Blue Shield organizations across the United States. HealthMedia partners include APS Healthcare, Corphealth, Health Dialog, Wellsource, and SHPS. For more information visit http://www.healthmedia.com
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Richard Bedrosian, PhD http://profnet.
'/>"/>

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
2. New Study: Pine Bark Significantly Reduces Menstrual Pain
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
5. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
6. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
7. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
8. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
9. Pharmaxis Long-Term Safety Study of Bronchitol Completes
10. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
11. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Blue Shield of California Expands CalPERS NetValue Service Area 52337 1Blue Shield of California Expands CalPERS NetValue Service Area 52337 2Blue Shield of California Expands CalPERS NetValue Service Area 52337 3Free Drug Card Has Saved Washington Residents 242 6 Million 52334 1Free Drug Card Has Saved Washington Residents 242 6 Million 52334 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 1Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 3Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 4Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 5Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 6Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 7Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 8
(Date:11/21/2009)... Eric J. Hall, president and chief executive off...) issued the following statement regarding the inc...f the new annual wellness for Medicare beneficiari...Care Act" that was introduced last night: , ...ber 21, 2009 -- Eric J. Hall, president and chief ...
(Date:11/20/2009)...NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharm...eting of Shareholders will be held on Monday, Dece...nsider approval of two special resolutions. The fi... the sale of all or substantially all of the asset...for in the asset purchase agreement dated November...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-elec... Care Vote , Washington, ...essmen running for re-election next year in races ... Cook, may come to regret voting for House Speaker...to a breaking Zogby International/ O’Leary R...
(Date:11/20/2009)..., Israel, November 20 Ca...p://www.CVSLMEDICAL.COM , a leading,developer of a...nnounced that,the company,s Board of Directors has..., Canada and the Far East for its proprietary next...ll angioplasty (PCTA) procedures. , Cardi...
(Date:11/20/2009)...d online November 20 in the Journal of the Nation...rs and hopes that often appear in news coverage of...for both the media and journals to help alleviate ... Steven Woloshin, M.D., M.S., of Center for Medici...alth Policy and Clinical Practice in New Hampshire...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...SING, Mich., Feb. 3 Cherries are not only good fo...per Fruit." According to recent,data, more than 9 ...comes,from, nearly 80 percent say they,re purchasi...f cherries consumed in the U.S. are grown here,wit...
...A BEACH, Va., Feb. 3, 2009 AMERIGROUP Corporation...y, Esq., MPH has been named Chief Compliance Offic...l Company operations comply with state and federal...ties at AMERIGROUP," said John E. Littel, AMERIGRO...
...NCISCO, Feb. 3 Nile Therapeutics, Inc., (Nasdaq: ...f Executive Officer, will present a corporate over...ference in New York. The presentation will take pl...linical-stage biopharmaceutical company that devel...
...MI, Feb. 3 Baker & McKenzie, and Bankstreet G...mit aimed at informing investors,in the healthcare...y 12th at,the Harvard Club. , Internationally ...of Miami and Palm Beach, Florida,( http://www.mors...
...will provide web foundation for the newly launched...., Feb. 3 Univita Health, a new company aimed at ...to independent aging, announced the acquisition of...eation of a virtual marketplace for individuals to...
...FANG, Shandong, China, Feb. 3 /PRNewswire-Asia-Fir...etin Board: SGTI) ("Shengtai Pharmaceutical" or,"t...or of high-quality,pharmaceutical grade glucose pr...ence. , This conference will be held from Mond...
Other Medicine News:Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 2Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 3Health News:AMERIGROUP Names Finley Chief Compliance Officer 2Health News:Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference 2Health News:James G. Schwade, M.D. to Deliver Keynote Address to Financial and Investment Industry in New York 2Health News:Univita Health Acquires Leading Web Services Company 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 3
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: